FINLIBDY

Live / Applied — Fourth extension granted (statement of use) (as of 22 Oct 2025)

What this means for you

Not registered yet, but its 23 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97560305
Mark type
Stylized text
Filed
23 Aug 2022
Published for opposition
10 Oct 2023
Attorney of record
Palak Mayani

Goods and services

  • Class 001 — Chemicals: Diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer
  • Class 042 — Scientific and technological services: Medical laboratory services, namely, laboratory testing for scientific research purposes and medical research services; medical laboratory services, namely, laboratory testing for scientific research purposes in the field of disease management and gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; medical laboratory services, namely, laboratory testing for scientific research of immune modulation and management of side effects associated with renal disorders and cancer pathology; medical laboratory services, namely, laboratory testing for scientific research of patient disease diagnoses and for patient selection for clinical trials
  • Class 044 — Medical, beauty and agricultural services: Health care services, namely, disease management programs; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to medical treatment recommendation; medical consultation; providing a website featuring information about medical services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; medical diagnostic testing provided by medical laboratories; medical analysis services in the nature of laboratory testing for disease management and patient diagnosis and patient selection for the diagnosis and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, provided by medical laboratories; medical analysis services relating to the treatment of patients in the nature of laboratory testing for the purpose of immune modulation and management of side effects associated with renal disorders and cancer, provided by medical laboratories

Owner

Prosecution history

  • 23 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 22 Oct 2025 — SOU EXTENSION 4 GRANTED
  • 22 Oct 2025 — SOU EXTENSION 4 FILED
  • 22 Oct 2025 — SOU TEAS EXTENSION RECEIVED
  • 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 27 May 2025 — SOU EXTENSION 3 GRANTED
  • 27 May 2025 — SOU EXTENSION 3 FILED
  • 27 May 2025 — SOU TEAS EXTENSION RECEIVED
  • 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 14 Feb 2025 — SOU EXTENSION 2 GRANTED
  • 13 Jan 2025 — SOU EXTENSION 2 FILED
  • 15 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 13 Jan 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 13 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 13 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

View this trademark record on Marksy